Latest Articles

Publication Date
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps - usatoday.com

Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps usatoday.com

Published: July 30, 2026, 11:49 p.m.
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps - USA Today

Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps USA Today

Published: July 30, 2026, 11:49 p.m.
Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer - Seeking Alpha

Karyopharm plummets as Xpovio fails in phase 3 trial for endometrial cancer Seeking Alpha

Published: July 30, 2026, 11:38 p.m.
Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study - FirstWord Pharma

Karyopharm slumps after Xpovio misses mark in Phase III endometrial cancer study FirstWord Pharma

Published: July 30, 2026, 9:59 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - TipRanks

Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint TipRanks

Published: July 30, 2026, 9:16 p.m.
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint - tipranks.com

Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint tipranks.com

Published: July 30, 2026, 9:16 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - Karyopharm

Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer Karyopharm

Published: July 30, 2026, 8:09 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - marketscreener.com

Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer marketscreener.com

Published: July 30, 2026, 8:07 p.m.
Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer - PR Newswire

Karyopharm Announces Topline Results from Phase 3 XPORT-EC-042 Trial in Endometrial Cancer PR Newswire

Published: July 30, 2026, 8:05 p.m.
Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps - markets.businessinsider.com

Lotus Endometriosis Institute Releases Guide On Missed Diagnosis Amid Care Gaps markets.businessinsider.com

Published: July 30, 2026, 3:58 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!